Cancer Screening

NIH modeling study looked at the individual and combined impacts of cancer prevention, screening, and treatment

AI-identified biomarker-based test reduces need for prostate biopsies in men with high PSA levels

The new CPT code establishes a reimbursement pathway for increased access and broader test adoption for patients at high risk for ovarian cancer

Some subtypes of endometriosis can raise patients’ cancer risk as much as 19-fold

New biomarker candidates may help determine which colon cancer patients are most likely to benefit from chemotherapy

Study finds PSA tests may give false reassurance for transgender women on estrogen therapy and could miss some cancers

New findings suggest pathway for screening high-risk individuals for pancreatic cancer in PRECEDE study

First genome-wide association study finds variants linked to susceptibility of cervical cancer-causing virus

The new screening method in trials includes two blood tests and an MRI scan of the prostate, if necessary

A blood test will be better than nothing, but may lead to more CRC cases and deaths than established screening tests